Figure 2.
Tandem [90Y]Y/[177Lu]Lu-DOTATATE therapy: Kaplan–Meier estimators of the progression-free survival after the initial PRRT (PFS I) in relation to the progression-free survival after the repeated PRRT (PFS II).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.